Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

E-Newsletter

  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent

    Archives

    Join Us

    News: Cancer News

    Carr, Manning honored by radiology research academy

    Thursday, August 27th, 2015

    Two leaders in imaging science at Vanderbilt University are among 37 recipients of the 2015 Distinguished Investigator Award from the Academy of Radiology Research (ARR), academy officials announced last week. They are J. Jeffrey Carr, M.D., M.Sc., the Cornelius Vanderbilt Professor of Radiology and Radiological Sciences, and H. Charles Manning, Ph.D., Vanderbilt Ingram Associate Professor of […]

    Songs from the Heart cancer event set for Sept. 26

    Thursday, August 27th, 2015

    Cancer affects many families, and patients and their relatives often struggle with an effective way to describe their feelings about the illness and its aftermath. Vanderbilt-Ingram Cancer Center (VICC) and Gilda’s Club Nashville give these individuals and their health care providers an opportunity to express themselves in song through the annual Songs from the Heart […]

    Arteaga lauded for cancer research contributions

    Thursday, August 27th, 2015

    Carlos L. Arteaga, M.D., the Donna S. Hall Professor of Breast Cancer and director of the Center for Cancer Targeted Therapies and the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been recognized for his cancer research efforts by the American-Italian Cancer Foundation (AICF). The AICF will also honor Frederick Alt, Ph.D., a Howard […]

    New type of trial shows promise for several cancers

    Monday, August 24th, 2015

    Anti-cancer drugs are typically tested on one type of cancer at a time. But an international consortium of cancer investigators, including Vanderbilt-Ingram Cancer Center (VICC) researchers, simultaneously tested an existing therapy in patients with several different forms of cancer that all exhibit the same tumor gene mutation. The new clinical trial showed promising results in […]

    Rathmell to lead new Center for Immunobiology

    Monday, August 24th, 2015

    Jeffrey Rathmell, Ph.D., has been recruited to Vanderbilt University Medical Center (VUMC) to lead a new Center for Immunobiology, a structure supported by the Department of Pathology, Microbiology and Immunology, the Department of Medicine and Vanderbilt-Ingram Cancer Center (VICC). Rathmell comes to Vanderbilt from Duke University Medical Center, Durham, North Carolina, where he serves as […]

    Rathmell to direct Division of Hematology and Oncology

    Thursday, August 13th, 2015

    W. Kimryn Rathmell, M.D., Ph.D., Alexander Professor for Translational Science and associate director for Training and Education at Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, has been named director of Vanderbilt’s Division of Hematology and Oncology. Rathmell is a physician-scientist whose research focuses on the genetic and molecular signals that drive renal […]

    Macara lands award to explore cancer cell behavior

    Thursday, August 13th, 2015

    Vanderbilt’s Ian Macara, Ph.D., has won an Outstanding Investigator Award from the National Cancer Institute (NCI) — nearly $6.6 million over seven years — to support the “unusual potential” of his research, which seeks to understand and predict cancer cell “behavior.” Macara, the Louise B. McGavock Professor and chair of the Department of Cell and […]

    Exercise during teen years linked to lowered risk of cancer death later

    Friday, August 7th, 2015

    Women who exercised during their teen years were less likely to die from cancer and all other causes during middle-age and later in life, according to a new study by investigators at Vanderbilt University Medical Center and the Shanghai Cancer Institute in China. The study was published online July 31 in Cancer Epidemiology, Biomarkers & […]

    New targeted therapy shows promise for rare joint tumor

    Friday, August 7th, 2015

    Vanderbilt-Ingram Cancer Center (VICC) investigators and colleagues at several major medical centers have been testing a new targeted therapy that is showing promise for the treatment of a rare tumor that forms in and around joint cavities. The study was published in the July 30 issue of The New England Journal of Medicine. Tenosynovial giant-cell […]

    Brown to head cancer registry for Y-90 tumor treatments

    Thursday, July 30th, 2015

    Dan Brown, M.D., professor of Radiology and Radiological Sciences and chief of Interventional Oncology, will spearhead a national Vanderbilt-led research registry that tracks cancer patients whose tumors are treated with Yttrium-90 (Y-90), a radioactive isotope. The Radiation-Emitting SIR-Spheres in Non-Resectable (RESIN) Liver Tumor Patient Registry is the result of a collaboration between VUMC, initially up […]

    Next Page »